Rhaeos
Bill Kabitz brings over 25 years of Quality Assurance and Regulatory Affairs experience working in government regulated and ISO certified design and manufacturing companies, including 18 years in management. He has led several teams through the design and implementation of FDA and ISO level Quality Management Systems where the organizations successfully obtained ISO 13485 Certification and successfully navigated them through FDA inspections.
He is a Certified Risk Specialist based on ISO 14971, with a practical application history in the Medical Device and Industrial Automation Industries. Bill holds a B.S. degree focused on Mechanical Design/CAD, and Technology Management from Herzing University.
This person is not in any teams
This person is not in any offices
Rhaeos
1 followers
Rhaeos is a VC backed, clinical stage medical device company developing FlowSense, a platform technology and a noninvasive wireless, wearable skin patch that can assess and monitor fluid flow subdermally throughout the body. The company is initially targeting hydrocephalus, a life threatening condition caused by an abnormal accumulation of cerebrospinal fluid (CSF). Implantable shunts, the gold standard treatment, often fail, leading to multiple trips to the emergency room and repeat surgeries. There is no technology available today that can easily assess CSF flow in shunts wirelessly, bedside, and without capital equipment until now.